NT-proBNP Predicts Cardiovascular Death in the General Population Independent of Left Ventricular Mass and Function: Insights from a Large Population-Based Study with Long-Term Follow-Up.
AIMS:B-type natriuretic peptide (BNP) and N-terminal proBNP (NT-proBNP) predict cardiovascular endpoints in patients and all-cause death in the general population. This was assigned to their association with clinical cardiac remodelling defined as changes in size, shape and function of the heart. Th...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5053441?pdf=render |
id |
doaj-38d464c36a3d402dadcce729e81e0691 |
---|---|
record_format |
Article |
spelling |
doaj-38d464c36a3d402dadcce729e81e06912020-11-25T02:36:42ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-011110e016406010.1371/journal.pone.0164060NT-proBNP Predicts Cardiovascular Death in the General Population Independent of Left Ventricular Mass and Function: Insights from a Large Population-Based Study with Long-Term Follow-Up.Alexander DietlKlaus StarkMartina E ZimmermannChrista MeisingerHeribert SchunkertChristoph BirnerLars S MaierAnnette PetersIris M HeidAndreas LuchnerAIMS:B-type natriuretic peptide (BNP) and N-terminal proBNP (NT-proBNP) predict cardiovascular endpoints in patients and all-cause death in the general population. This was assigned to their association with clinical cardiac remodelling defined as changes in size, shape and function of the heart. The aim of this study was to evaluate whether NT-proBNP and BNP were associated with cardiovascular and overall death independent of clinical cardiac remodelling measured by echocardiography as left ventricular hypertrophy (LVH), diastolic dysfunction and left ventricular ejection fraction (EF). METHODS AND RESULTS:In a general population-based cohort study from Germany (KORA-S3) with subjects' baseline age ranging from 25 to 74 years, cardiac morphology and function were assessed as left ventricular mass (LVM), diastolic dysfunction and EF by echocardiography and circulating NT-proBNP and BNP were measured at baseline. In 1,223 subjects with mortality follow-up information, we examined the association of baseline NT-proBNP and BNP with cardiovascular mortality (number of deaths = 52, median follow-up time = 12.9years) using Cox regression without and with adjustment for cardiovascular risk factors, LVM, diastolic dysfunction and EF. The risk of cardiovascular mortality increased with higher NT-proBNP levels measured at baseline (hazard ratio HR = 1.67 per unit increment in logNT-proBNP, p = 2.78*10-4, adjusted for age and sex). This increased risk persisted after adjustment for cardiovascular risk factors, LVM, diastolic dysfunction and EF (HR = 1.73; p = 0.047). When excluding subjects with relevant LVH (LVM to body surface area > 149g/m2 in men / 122g/m2 in women), the NT-proBNP association with mortality was still significant (n = 1,138; number of deaths = 35; HR = 1.48; p = 0.04). We found similar results for BNP. CONCLUSION:Our data confirms NT-proBNP and BNP as predictor of cardiovascular mortality in a large general population-based study with long-term follow-up. Our study extends previously published population-based studies to younger and potentially healthier individuals without relevant LVH, diastolic dysfunction or LVD.http://europepmc.org/articles/PMC5053441?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Alexander Dietl Klaus Stark Martina E Zimmermann Christa Meisinger Heribert Schunkert Christoph Birner Lars S Maier Annette Peters Iris M Heid Andreas Luchner |
spellingShingle |
Alexander Dietl Klaus Stark Martina E Zimmermann Christa Meisinger Heribert Schunkert Christoph Birner Lars S Maier Annette Peters Iris M Heid Andreas Luchner NT-proBNP Predicts Cardiovascular Death in the General Population Independent of Left Ventricular Mass and Function: Insights from a Large Population-Based Study with Long-Term Follow-Up. PLoS ONE |
author_facet |
Alexander Dietl Klaus Stark Martina E Zimmermann Christa Meisinger Heribert Schunkert Christoph Birner Lars S Maier Annette Peters Iris M Heid Andreas Luchner |
author_sort |
Alexander Dietl |
title |
NT-proBNP Predicts Cardiovascular Death in the General Population Independent of Left Ventricular Mass and Function: Insights from a Large Population-Based Study with Long-Term Follow-Up. |
title_short |
NT-proBNP Predicts Cardiovascular Death in the General Population Independent of Left Ventricular Mass and Function: Insights from a Large Population-Based Study with Long-Term Follow-Up. |
title_full |
NT-proBNP Predicts Cardiovascular Death in the General Population Independent of Left Ventricular Mass and Function: Insights from a Large Population-Based Study with Long-Term Follow-Up. |
title_fullStr |
NT-proBNP Predicts Cardiovascular Death in the General Population Independent of Left Ventricular Mass and Function: Insights from a Large Population-Based Study with Long-Term Follow-Up. |
title_full_unstemmed |
NT-proBNP Predicts Cardiovascular Death in the General Population Independent of Left Ventricular Mass and Function: Insights from a Large Population-Based Study with Long-Term Follow-Up. |
title_sort |
nt-probnp predicts cardiovascular death in the general population independent of left ventricular mass and function: insights from a large population-based study with long-term follow-up. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2016-01-01 |
description |
AIMS:B-type natriuretic peptide (BNP) and N-terminal proBNP (NT-proBNP) predict cardiovascular endpoints in patients and all-cause death in the general population. This was assigned to their association with clinical cardiac remodelling defined as changes in size, shape and function of the heart. The aim of this study was to evaluate whether NT-proBNP and BNP were associated with cardiovascular and overall death independent of clinical cardiac remodelling measured by echocardiography as left ventricular hypertrophy (LVH), diastolic dysfunction and left ventricular ejection fraction (EF). METHODS AND RESULTS:In a general population-based cohort study from Germany (KORA-S3) with subjects' baseline age ranging from 25 to 74 years, cardiac morphology and function were assessed as left ventricular mass (LVM), diastolic dysfunction and EF by echocardiography and circulating NT-proBNP and BNP were measured at baseline. In 1,223 subjects with mortality follow-up information, we examined the association of baseline NT-proBNP and BNP with cardiovascular mortality (number of deaths = 52, median follow-up time = 12.9years) using Cox regression without and with adjustment for cardiovascular risk factors, LVM, diastolic dysfunction and EF. The risk of cardiovascular mortality increased with higher NT-proBNP levels measured at baseline (hazard ratio HR = 1.67 per unit increment in logNT-proBNP, p = 2.78*10-4, adjusted for age and sex). This increased risk persisted after adjustment for cardiovascular risk factors, LVM, diastolic dysfunction and EF (HR = 1.73; p = 0.047). When excluding subjects with relevant LVH (LVM to body surface area > 149g/m2 in men / 122g/m2 in women), the NT-proBNP association with mortality was still significant (n = 1,138; number of deaths = 35; HR = 1.48; p = 0.04). We found similar results for BNP. CONCLUSION:Our data confirms NT-proBNP and BNP as predictor of cardiovascular mortality in a large general population-based study with long-term follow-up. Our study extends previously published population-based studies to younger and potentially healthier individuals without relevant LVH, diastolic dysfunction or LVD. |
url |
http://europepmc.org/articles/PMC5053441?pdf=render |
work_keys_str_mv |
AT alexanderdietl ntprobnppredictscardiovasculardeathinthegeneralpopulationindependentofleftventricularmassandfunctioninsightsfromalargepopulationbasedstudywithlongtermfollowup AT klausstark ntprobnppredictscardiovasculardeathinthegeneralpopulationindependentofleftventricularmassandfunctioninsightsfromalargepopulationbasedstudywithlongtermfollowup AT martinaezimmermann ntprobnppredictscardiovasculardeathinthegeneralpopulationindependentofleftventricularmassandfunctioninsightsfromalargepopulationbasedstudywithlongtermfollowup AT christameisinger ntprobnppredictscardiovasculardeathinthegeneralpopulationindependentofleftventricularmassandfunctioninsightsfromalargepopulationbasedstudywithlongtermfollowup AT heribertschunkert ntprobnppredictscardiovasculardeathinthegeneralpopulationindependentofleftventricularmassandfunctioninsightsfromalargepopulationbasedstudywithlongtermfollowup AT christophbirner ntprobnppredictscardiovasculardeathinthegeneralpopulationindependentofleftventricularmassandfunctioninsightsfromalargepopulationbasedstudywithlongtermfollowup AT larssmaier ntprobnppredictscardiovasculardeathinthegeneralpopulationindependentofleftventricularmassandfunctioninsightsfromalargepopulationbasedstudywithlongtermfollowup AT annettepeters ntprobnppredictscardiovasculardeathinthegeneralpopulationindependentofleftventricularmassandfunctioninsightsfromalargepopulationbasedstudywithlongtermfollowup AT irismheid ntprobnppredictscardiovasculardeathinthegeneralpopulationindependentofleftventricularmassandfunctioninsightsfromalargepopulationbasedstudywithlongtermfollowup AT andreasluchner ntprobnppredictscardiovasculardeathinthegeneralpopulationindependentofleftventricularmassandfunctioninsightsfromalargepopulationbasedstudywithlongtermfollowup |
_version_ |
1724798522848444416 |